Retina accumulates more glucose than does the embryologically similar cerebral cortex in diabetic rats

Diabetologia

Volumn 43, Issue 11, 2000, Pages 1417-1423

  Tang, J ^a   Zhu, X W ^b   Lust, W D ^b   Kern, T S ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Amadori product; Brain; Diabetic retinopathy; Glucose transporter; Hyperglycaemia; Retina

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DIABETES MELLITUS; EMBRYOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; RETINA; RETINA BLOOD VESSEL; TISSUE HOMOGENATE; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; CELL MEMBRANE; CEREBRAL CORTEX; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RETINAL VESSELS;

EID: 0033736057     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051548     Document Type: Article

References (46)

1. Experimental galactosemia produces diabetic-like retinopathy
2. The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus
3. Relationship of microvascular disease in diabetes to metabolic control
4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes
5. Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemia
6. Pericytes in diabetic retinopathy
7. Degeneration of intramural pericytes in diabetic retinopathy
8. Brain-type glucose transporter (Glut-1) is selectively localized to the blood-brain border
9. The effects of an aldose reductase inhibitor upon the sorbitol pathway, fructose-1-phosphate and lactate in the retina and nerve of streptozotocin-diabetic rats
10. Glucose, glucose-phosphate, lactate and pyruvate content of the retina, blood and liver of streptozotocin-diabetic rats fed sucroseor starch-rich diets
11. Polyol accumulations in nervous tissue of rats with experimental diabetes and galactosaemia
12. Brain energy metabolism in streptozotocin-diabetes
13. Myo-inositol normalizes decreased sodium permeability of the blood-brain barrier in streptozotocin diabetes
14. The Amadori product on protein: Structure and reactions
15. Glycation products and the pathogenesis of diabetic complications
16. Methods of fixation of nervous tissue for use in the study of cerebral enerby metabolism
17. Decreased energy metabolism in brain stem during central respiratory depression in response to hypoxia
18. A rapid and sensitive method for the quantitation of microgram quantities of protein
19. Glut1 and Glut3 expression, but not capillary density, is increased by cobalt chloride in rat cerebrum and retina
20. Isolation and partial characterization of the luminal plasmalemma of microvascular endothelium from rat lungs
21. Caveolae from luminal plasmalemma of rat lung endothelium: Microdomains enriched in caveolin, Ca(2+)-ATPase, and inositol trisphosphate receptor
22. P-Glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain
23. Identification of endothelial cell-surface proteins as targets for diagnosis and treatment of disease
24. Retinal polyol and myoinositol in galactosemic dogs given an aldose reductase inhibitor
25. Correlation of diacylglycerol and protein kinase C in rat retina to retinal circulation
26. Galactose-induced retinal microangiopathy in rats
27. Biochemical and molecular mechanisms in the development of diabetic vascular complications
28. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants
29. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system
30. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. V. Relationship between protein kinase C and ATPases
31. Abnormalities of retinal metabolism in diabetes or galactosemia II. Comparison of gamma-glutamyl transpeptidase in retina and cerebral cortex, and effects of antioxidant therapy
32. Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozocin-induced diabetic rats
33. Effects of aminoguanidine on hyperglycaemia-induced retinal metabolic abnormalities
34. 13C NMR spectroscopy
35. Diabetes down-regulates Glut1 expression in retina and its microvessels, but not in cerebral cortex or its microvessels
36. Pathological upregulation of inner blood-retinal barrier GLUT-1 glucose transporter expression in diabetes mellitus
37. Retinal and choroidal contribution to retinal metabolism in vivo. A study in pigs
38. Ultracytochemical localization of the erythrocyte/ HepG2-type glucose transporter (GLUT1) in cells of the blood-retinal barrier in the rat
39. GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye
40. Vascular filtration function in galactose-fed versus diabetic rats: The role of polyol pathway activity
41. Effects of islet isografts on hemodynamic and vascular filtratration changes in diabetic rats
42. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats
43. Central nervous system complications of diabetes mellitus - A perspective from the blood-brain barrier
44. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors
45. Discordant effects of the aldose reductase inhibitor sorbinil an vascular structure and function in chronically diabetic and galactosemic rats
46. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin